A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: Association study with mutations in the core and NS5A region of hepatitis C virus

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Nagao, Yumiko ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INTERFERON; NONSTRUCTURAL PROTEIN 5A; VIRUS RNA; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; SERUM ALBUMIN; VIRUS ANTIBODY; VIRUS PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; HYPOALBUMINEMIA; INFECTION RATE; JAPAN; LICHEN PLANUS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NS5A GENE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; VIRUS GENE; VIRUS LOAD; VIRUS MUTATION; BLOOD; GENETICS; HEPATITIS C VIRUS; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; RISK; STATISTICAL MODEL; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; JAPAN; LICHEN PLANUS, ORAL; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; SERUM ALBUMIN; SMOKING; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84859485212     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-31     Document Type: Article

References (41)

1. Asahina Y, Tsuchiya K, Tamaki N, Hirayama I, Tanaka T, Sato M, Yasui Y, Hosokawa T, Ueda K, Kuzuya T, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Enomoto N, Izumi N. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology 2010, 52:518-527. 10.1002/hep.23691, 20683951.
2. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995, 96:224-230. 10.1172/JCI118025, 185192, 7542279.
3. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996, 334:77-81. 10.1056/NEJM199601113340203, 8531962.
4. Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Matsuda M, Kobayashi M, Arase Y, Ikeda K, Kumada H. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype1b high viral load and nonvirological response to interferon-ribavirin combination therapy. Intervirology 2005, 48:372-380. 10.1159/000086064, 16024941.
5. Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H. Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels. J Hepatol 2007, 46:403-410. 10.1016/j.jhep.2006.09.019, 17126448.
6. Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Hepatology 2007, 46:1357-1364. 10.1002/hep.21836, 17657816.
7. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995, 123:615-620.
8. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, Deforges L, Duvoux C, Zafrani ES, Duval J. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841-848. 10.1002/hep.1840190407, 8138255.
9. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, Yamamoto AM, Camproux AC, Hausfater P, Musset L, Veyssier P, Raguin G, Piette JC. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000, 79:47-56.
10. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002, 36:1439-1445.
11. Jubert C, Pawlotsky JM, Pouget F, Andre C, DeForges L, Bretagne S, Mavier JP, Duval J, Revuz J, Dhumeaux D, Bagot M. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994, 130:73-76. 10.1001/archderm.1994.01690010077011, 8285744.
12. Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest 1995, 25:910-914. 10.1111/j.1365-2362.1995.tb01966.x, 8719930.
13. Carrozzo M, Gandolfo S, Carbone M, Colombatto P, Broccoletti R, Garzino-Demo P, Ghisetti V. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 1996, 25:527-533. 10.1111/j.1600-0714.1996.tb01726.x, 8986963.
14. Bagán JV, Ramón C, González L, Diago M, Milián MA, Cors R, Lloria E, Cardona F, Jiménez Y. Preliminary investigation of the association of oral lichen planus and hepatitis C. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85:532-536. 10.1016/S1079-2104(98)90286-4, 9619669.
15. Figueiredo LC, Carrilho FJ, de Andrage HF, Migliari DA. Oral lichen planus and hepatitis C virus infection. Oral Dis 2002, 8:42-46. 10.1034/j.1601-0825.2002.10763.x, 11939174.
16. Carrozzo M. Oral diseases associated with hepatitis C virus infection. Part 2: Lichen Planus and other diseases. Oral Dis 2008, 14:217-228. 10.1111/j.1601-0825.2007.01432.x, 18221456.
17. Nagao Y, Sata M, Itoh K, Tanikawa K, Kameyama T. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 1996, 26:495-498. 10.1046/j.1365-2362.1996.167314.x, 8817164.
18. Lodi G, Carrozzo M, Hallett R, D'Amico E, Piattelli A, Teo CG, Gandolfo S, Carbone M, Porter SR. HCV genotypes in Italian patients with HCV-related oral lichen planus. J Oral Pathol Med 1997, 26:381-384. 10.1111/j.1600-0714.1997.tb00235.x, 9379429.
19. Sata M, Nakano H, Suzuki H, Noguchi S, Yamakawa Y, Tanaka E, Fukuizumi K, Tanaka K, Yoshida H, Tanikawa K. Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan. J Gastroenterol 1998, 33:218-222. 10.1007/s005350050073, 9605952.
20. Fukuizumi K, Sata M, Suzuki H, Nakano H, Tanikawa K. Hepatitis C virus seroconversion rate in a hyper-endemic area of HCV in Japan: a prospective study. Scand J Infect Dis 1997, 29:345-347. 10.3109/00365549709011828, 9360247.
21. Fukuizumi K, Sata M, Suzuki H, Kumashiro R, Tanikawa K. Natural disappearance of serum HCV RNA; prospective study in a hyperendemic area. Hepatol Res 1997, 9:144-151.
22. Noguchi S, Sata M, Suzuki H, Mizokami M, Tanikawa K. Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection. Scand J Infect Dis 1997, 29:23-28. 10.3109/00365549709008659, 9112293.
23. Nagao Y, Fukuizumi K, Tanaka K, Kumashiro R, Sata M. The prognosis for life in an HCV hyperendemic area. Gastroenterology 2003, 125:628-629. 10.1016/S0016-5085(03)00972-7, 12891577.
24. Nagao Y, Tanaka K, Kobayashi K, Kumashiro R, Sata M. A cohort study of chronic liver disease in an HCV hyperendemic area of Japan: a prospective analysis for 12 years. Int J Mol Med 2004, 13:257-265.
25. Nagao Y, Tanaka K, Kobayashi K, Kumashiro R, Sata M. Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan. Hepatol Res 2004, 28:30-35. 10.1016/j.hepres.2003.08.005, 14734148.
26. Nagao Y, Sata M, Fukuizumi K, Tanikawa K, Kameyama T. High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection. Hepatol Res 1997, 8:173-177.
27. Nagao Y, Sata M, Fukuizumi K, Ryu F, Ueno T. High incidence of oral lichen planus in an HCV hyperendemic area. Gastroenterology 2000, 119:882-883.
28. Nagao Y, Kawaguchi T, Tanaka K, Kumashiro R, Sata M. Extrahepatic manifestations and insulin resistance in an HCV hyperendemic area. Int J Mol Med 2005, 16:291-296.
29. Lee SC, Antony A, Lee N, Leibow J, Yang JQ, Soviero S, Gutekunst K, Rosenstraus M. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol 2000, 38:4171-4179. 87559, 11060086.
30. Sizmann D, Boeck C, Boelter J, Fischer D, Miethke M, Nicolaus S, Zadak M, Babiel R. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol 2007, 38:326-333. 10.1016/j.jcv.2006.12.021, 17344093.
31. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, Simmonds P. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994, 19:13-18. 10.1002/hep.1840190104, 8276349.
32. Petti S, Rabiei M, De Luca M, Scully C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology 2011, 99:168-178. 10.1007/s10266-011-0008-3, 21505737.
33. Antonucci G, Longo MA, Angeletti C, Vairo F, Oliva A, Comandini UV, Tocci G, Boumis E, Noto P, Solmone MC, Capobianchi MR, Girardi E. The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr. Am J Gastroenterol 2007, 102:1383-1391. 10.1111/j.1572-0241.2007.01201.x, 17403072.
34. Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, Yamada G, Yokosuka O, Shiratori Y, Omata M. Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology 2002, 123:483-491. 10.1053/gast.2002.34785, 12145802.
35. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009, 41:1105-1109. 10.1038/ng.449, 19749757.
36. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461:399-401. 10.1038/nature08309, 19684573.
37. Carrozzo M, Francia Di Celle P, Gandolfo S, Carbone M, Conrotto D, Fasano ME, Roggero S, Rendine S, Ghisetti V. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol 2001, 144:803-808. 10.1046/j.1365-2133.2001.04136.x, 11298540.
38. Nagao Y, Myoken Y, Katayama K, Tanaka J, Yoshizawa H, Sata M. Epidemiological survey of oral lichen planus among HCV-infected inhabitants in a town in Hiroshima Prefecture in Japan from 2000 to 2003. Oncol Rep 2007, 18:1177-1181.
39. Nagao Y, Sata M. Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan. Virol J 2010, 7:375. 10.1186/1743-422X-7-375, 3022684, 21194423.
40. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Rossi Fanelli F, Abbiati R. Italian BCAA Study Group Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: A double blind, randomized trial. Gastroenterology 2003, 124:1792-1801. 10.1016/S0016-5085(03)00323-8, 12806613, Italian BCAA Study Group.
41. Cynober L, Harris RA. Symposium on branched-chain amino acids: conference summary. J Nutr 2006, 136(1 Suppl):333S-336S.